Fortitude Provides Second Quarter 2026 Financial and Operating Highlights
HSCS could react positively if the Fortitude deal closes in H2 2026; monitor regulatory approvals.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
HSCS could react positively if the Fortitude deal closes in H2 2026; monitor regulatory approvals.
What happened and why it matters
Fortitude Mining reported Q2 revenue of $20.9 million and Adjusted EBITDA of $8.5 million, mining ~33,646 ZEC at 4.0 GSol/s and expanding power to 60+ MW. It disclosed a private placement purchasing 411,522 HeartSciences shares at VWAP $2.43, giving Fortitude ~9.4% ownership as the companies pursue a H2 2026 closing of their business combination. The deal could accelerate HeartSciences' path to public markets and strengthen its balance sheet.
Deal progress and Fortitude’s material HSCS stake could reduce funding risk and support a valuation re-rate for HSCS; similar past announcements often trigger initial upside on visibility, though closing risk remains.
Q2 revenue $20.9M; Adjusted EBITDA $8.5M; ZEC mined ~33,646.
Hash rate 4.0 GSol/s; power portfolio 60+ MW across seven sites.
Fortitude bought $1.0M HeartSciences stock; private placement; closing H2 2026.
Proposed Fortitude-HeartSciences business combination expected to close in H2 2026.
Category: M&A. The article centers on a proposed business combination and related financing, implying near-term HSCS valuation and liquidity implications should the deal progress toward a 2026 close.
More AI-analyzed coverage connected to this story